DIA438.00+4.07 0.94%
SPX6,173.07+32.05 0.52%
IXIC20,273.46+105.55 0.52%

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga·06/28/2023 17:04:06
Listen to the news

Gainers

  • Minerva Neurosciences, Inc. (NASDAQ:NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.
  • Kaleyra, Inc. (NYSE:KLR) shares jumped 38.3% to $6.64 after Tata Communications Limited announced it has entered an agreement to acquire the company.
  • Theriva Biologics, Inc. (NYSE:TOVX) shares jumped 30.6% to $1.0808 after the company said Orphan Drug Designation was granted by the U.S. Food and Drug Administration for VCN-01 for the treatment of pancreatic cancer.
  • Joby Aviation, Inc. (NYSE:JOBY) gained 26.4% to $8.08 after the company announced it received a permit that allows the company to begin flight testing of its first production prototype.
  • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) shares gained 22.4% to $9.12.
  • Xponential Fitness, Inc. (NYSE:XPOF) surged 18.1% to $18.57.
  • JX Luxventure Limited (NASDAQ:JXJT) rose 17.4% to $2.36.
  • Motorcar Parts of America, Inc. (NASDAQ:MPAA) gained 16.3% to $8.19.
  • Archer Aviation Inc. (NYSE:ACHR) rose 15.6% to $3.92. Stellantis reported a 10.6% stake in Archer Aviation Class A Common Stock as of June 23.
  • IronNet, Inc. (NYSE:IRNT) gained 14.8% to $0.23.
  • Doma Holdings Inc. (NYSE:DOMA) surged 13.8% to $0.2026.
  • Lichen China Limited (NASDAQ:LICN) rose 13.5% to $1.51.
  • Opendoor Technologies Inc. (NASDAQ:OPEN) jumped 13.3% to $3.8550.
  • eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) gained 11.3% to $0.7001.
  • Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares climbed 11.1% to $0.4776 after declining around 14% on Tuesday. Avalo Therapeutics recently announced its Phase 2 Peak trial For quisovalimab In patients With non-eosinophilic asthma missed its primary endpoint.
  • Viad Corp (NYSE:VVI) gained 10.5% to $26.82. Craig-Hallum initiated coverage on Viad with a Buy rating and announced a price target of $40.
  • National CineMedia, Inc. (NASDAQ:NCMI) shares rose 10.4% to $0.3450. National CineMedia said plan of reorganization has been confirmed by the United States Bankruptcy Court.
  • Fathom Digital Manufacturing Corporation (NYSE:FATH) gained 10.4% to $0.35.
  • Beazer Homes USA, Inc. (NYSE:BZH) climbed 10.2% to $27.15. Wedbush upgraded Beazer Homes USA from Neutral to Outperform.
  • iMedia Brands, Inc. (NASDAQ:IMBI) shares rose 9.6% to $0.1767 after dropping over 15% on Tuesday. iMedia Brands recently announced receipt of second Nasdaq non-compliance notice.
  • Edgio, Inc. (NASDAQ:EGIO) gained 7.1% to $0.6478 after declining 3% on Tuesday.
  • Pinterest, Inc. (NYSE:PINS) climbed 6.1% to $28.00 after Wells Fargo upgraded the stock to Overrweight from Equal-Weight.

Losers

  • American Rebel Holdings, Inc. (NASDAQ:AREB) fell 31.4% to $3.7750 after jumping 17% on Tuesday. American Rebel recently announced a 1-for-25 reverse stock split.
  • AST SpaceMobile, Inc. (NASDAQ:ASTS) shares fell 29.3% to $4.5050 after the company announced pricing of an upsized offering of Class A common stock.
  • Leafly Holdings, Inc. (NASDAQ:LFLY) fell 24.1% to $0.2809. Leafly was granted U.S. patent #11687994 for "Systems For Selection Of Cannabis-Related Products And Visualization Of Chemical Data (The Decision Engine May Implement Artificial Intelligence)."
  • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) dropped 23% to $0.52 after announcing $2.25 million registered direct offering of 5 million at $0.45/share.
  • Cognition Therapeutics, Inc. (NASDAQ:CGTX) fell 22.8% to $1.93 after the company reported topline results from its Phase 2 SEQUEL study of Ct1812 in 16 adults with mild-to-moderate Alzheimer's disease.
  • EdtechX Holdings Acquisition Corp. II (NASDAQ:EDTX) dropped 20.2% to $12.51.
  • Tivic Health Systems, Inc. (NASDAQ:TIVC) fell 17.3% to $0.1150. Tivic Health Systems shares gained 39% on Tuesday after the company announced that it entered into a non-exclusive distribution agreement with Cardinal Health.
  • Benitec Biopharma Inc. (NASDAQ:BNTC) declined 16.3% to $0.2258.
  • Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) dipped 15% to $5.25. HC Wainwright & Co. upgraded Black Diamond Therapeutic from Neutral to Buy and maintained $11 price target.
  • Mullen Automotive, Inc. (NASDAQ:MULN) fell 14.8% to $0.1165. The company announced Tuesday that on June 23 its Series D investors exercised their final option, expiring June 30, for $100 million.
  • Eton Pharmaceuticals, Inc. (NASDAQ:ETON) dropped 14.8% to $3.4397 after the FDA issued complete response letter to dehydrated alcohol injection for methanol poisoning.
  • NovaGold Resources Inc. (NYSE:NG) fell 11.6% to $4.0401 after the company announced second-quarter results.
  • Surgalign Holdings, Inc. (NASDAQ:SRGA) shares dropped 11.3% to $0.2394 after jumping 19% on Tuesday. Surgalign recently received NASDAQ delisting notice following its Chapter 11 filing.
  • Axsome Therapeutics, Inc. (NASDAQ:AXSM) fell 11.2% to $74.01 after the company's proposed public offering of common stock.
  • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) fell 9.2% to $0.4356.
  • Siyata Mobile Inc. (NASDAQ:SYTA) shares dropped 7.6% to $0.0535. Siyata Mobile shares dipped around 35% on Tuesday after the company priced a 50 million share offering at $0.045 per share.
  • Regencell Bioscience Holdings Limited (NASDAQ:RGC) fell 7.5% to $21.28.
  • Digital Media Solutions, Inc. (NYSE:DMS) shares fell 7.1% to $0.33 after dropping over 12% on Tuesday.
  • TeraWulf Inc. (NASDAQ:WULF) dropped 6.3% to $1.7150.
  • General Mills, Inc. (NYSE:GIS) fell 5.3% to $76.58 after the company reported a fourth-quarter revenue miss.

 

Now Read This: Top 5 Real Estate Stocks That May Collapse In Q2

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.